Sonoma Pharmaceuticals (SNOA) FCF Margin (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly FCF Margin of 18.65% in Q4 2025, down 62.02% quarter-over-quarter from 11.51% in Q3 2025, and down 3444.0% on a YoY basis from 0.56% in Q4 2024.
Sonoma Pharmaceuticals (SNOA) FCF Margin (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' FCF Margin history runs 16 years deep, the most recent figure standing at 18.65% for Q4 2025.
- In Q4 2025, FCF Margin fell 3444.0% year-over-year to 18.65%; the TTM figure through Dec 2025 stood at 20.99% (down 2202.0% YoY), while the FY2025 annual figure was 1.18%, up 1767.0% from the prior year.
- FCF Margin was 18.65% for Q4 2025 at Sonoma Pharmaceuticals, down from 11.51% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 15.8% in Q4 2024 to a low of 87.29% in Q1 2023.
- Historically, FCF Margin has averaged 28.97% across 5 years, with a median of 30.78% in 2021.
- The sharpest annual moves came in 2024 and 2025: FCF Margin surged 9224 bps in 2024, then sank 3444 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 11.27% in 2021, then fell by 14 bps to 12.87% in 2022, then plunged by 174 bps to 35.21% in 2023, then surged by 145 bps to 15.8% in 2024, then sank by 218 bps to 18.65% in 2025.
- The last three FCF Margin figures came in at 18.65% (Q4 2025), 11.51% (Q3 2025), and 52.83% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -429.96% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 32.62% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 13.24% |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | -18.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.65% |
| Sep 30, 2025 | -11.51% |
| Jun 30, 2025 | -52.83% |
| Mar 31, 2025 | -3.78% |
| Dec 31, 2024 | 15.80% |
| Sep 30, 2024 | 9.16% |
| Jun 30, 2024 | -27.04% |
| Mar 31, 2024 | 4.94% |
| Dec 31, 2023 | -35.21% |
| Sep 30, 2023 | -45.15% |
| Jun 30, 2023 | -6.77% |
| Mar 31, 2023 | -87.29% |
| Dec 31, 2022 | -12.87% |
| Sep 30, 2022 | -55.69% |
| Jun 30, 2022 | -39.07% |
| Mar 31, 2022 | -63.40% |
| Dec 31, 2021 | -11.27% |
| Sep 30, 2021 | -35.50% |
| Jun 30, 2021 | -34.53% |
| Mar 31, 2021 | -68.66% |